Look up one drug

Ontario coverage, price, criteria word for word, Health Canada status and shortages for one product

Patient plan: look up a medication list

MEBENDAZOLE

All products: general benefit

Vermox · DIN 00556734 · 100mg · tablet

General benefitMarketed · checked 2026-09-02
StatusGeneral benefit
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
No interchangeable product listed in the Ontario extract
Vermox · DIN 00556734 Manufacturer: Janssen Inc.; listing date 1996-10-01 Health Canada: Marketed since 2001-11-08 · brand VERMOX · ATC P02CA01 MEBENDAZOLE · form Tablet · route Oral · ingredients MEBENDAZOLE 100 MG · company Janssen inc · schedule Prescription
Check this DIN again · Health Canada product record

Vermox: Formulary list price $10.4950/unit (unit not stated in source; not the patient's cost)

Ministry pays: $10.4950 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=4743 · Verify on the e-Formulary ↗ (DIN 00556734)

Source record
DIN 00556734: Vermox Raw flags: sec3=Y Item: 080800013; group id 5; item number 0007; lccId None; manufacturer id JAN Source form: Tab; strength: 100mg Recorded listing: General benefit Source prices (unrounded): $10.4950; ministry $10.4950 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=00556734 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=4743
Shortage status: no shortage or discontinuation reported (checked 2026-09-13T08:10:21.292534+00:00); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=00556734
Shortage record checked 2026-09-13T08:10:21.292534+00:00
Other drugs in the same formulary class (08:08 Anthelmintics) and how they are covered
No products matched this class search: “08:08”. This is a search result, not a decision about coverage. Try a different class name, abbreviation or class code. Search this as a medication name or DIN
Full class listing Related classes: 08:12 Antibiotics, 08:14 Antifungals, 08:16 Antitubercular Agents, 08:18 Antivirals, 08:20 Plasmodicides (Antimalarials), 08:24 Sulfonamides, 08:30 Antiprotozoals, 08:32 Trichomonacides, 08:36 Urinary Anti-Infectives, 08:40 Miscellaneous Anti-Infectives Same formulary class, not same indication: class membership alone does not establish equivalent uses.
What the Health Canada label says it is for
1 INDICATIONS Vermox (mebendazole) is indicated for a broad spectrum of anthelmintic activity and is effective in the treatment of single or mixed helminthic infestations. Clinical studies have shown it to be effective in the treatment of Enterobius vermicularis (pinworm); Ascaris lumbricoides (roundworm); Trichuris trichiura (whipworm); Ancylostoma duodenale and Necator americanus (hookworm). It has also been used to treat infestations due to Strongyloides stercoralis (threadworm) and Taenia solium (large tapeworms). 1.1 Pediatrics Pediatrics (1 to <18 years of age): Based on the data submitted and reviewed by Health Canada, the safety and efficacy of Vermox in pediatric patients has been established. Therefore, Health Canada has authorized an indication for pediatric use (see 7.1.3 Pediatrics). https://pdf.hres.ca/dpd_pm/00076701.PDF PM date: July 8, 1975 Source product: VERMOX; DIN 00556734; fetched 2026-09-10 Product monograph posted by Health Canada; excerpt for lookup only.